pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Voyxact · news · pharmadog
← back to Voyxact
News mentioning Voyxact
11
stories
12d
Vertex opens up larger kidney disease opportunity with mid-stage readout
biospace
Aug 17, 26
Vera’s newly approved IgA nephropathy drug supports kidney function, like Otsuka’s Voyxact
biospace
Aug 12, 26
Boulevard starts up with $65M to pursue targeted autoimmune drugs
biopharma dive
Aug 4, 26
Otsuka succeeds with kidney drug; BioNTech downgrades revenue projection
endpoints
Aug 4, 26
Vertex unfazed by competitive IgAN space as FDA verdict looms
biospace
Jul 7, 26
Vera Therapeutics wins FDA nod for closely watched kidney disease drug
biopharma dive
Jul 2, 26
Otsuka reports long-term kidney data key to Voyxact's bid for full approval
endpoints
Jul 1, 26
BridgeBio gets funding for drug launch; United buys into cell therapy
biopharma dive
Jun 4, 26
Otsuka touts new IgAN evidence as it seeks full approval for Voyxact
endpoints
Jun 4, 26
STAT+: Otsuka kidney drug slowed loss of function, but less than expected, in late-stage trial
stat
Jun 4, 26
Otsuka showcases kidney drug data; Pfizer cuts an AI deal
biopharma dive
